Sp131
PERSONALIZED NUTRITION 101
Date
May 6, 2023
Explore related products in the following collection:
Society: AGA
The literature in personalized nutrition in healthcare has been expanding. This program will review the scientific principles of nutritional genomics and metabalomics in predicting and impacting health and disease. The role of circadian rhythm physiology in disease and its role in guiding dietary to impact the gut microbiome-immune axis in health and potentially disease-will also be discussed.
The literature in personalized nutrition in healthcare has been expanding. This program will review the scientific principles of nutritional genomics and metabalomics in predicting and impacting health and disease. The role of circadian rhythm physiology in disease and its role in guiding dietary to impact the gut microbiome-immune axis in health and potentially disease-will also be discussed.
Presenter
Tracks
Related Products
MONITORING OF CALPROTECTIN IN INFLAMMATORY BOWEL DISEASE USING A SWEAT BASED WEARABLE DEVICE
Switching from originator to biosimilar infliximab (IFX) is effective and safe. However, data on multiple switching are scarce. The Edinburgh IBD unit has undertaken three switch programmes: (1) Remicade to CT-P13 (2016), (2) CT-P13 to SB2 (2020), and (3) SB2 to CT-P13 (2021)…
INTRODUCTION
SOCIETY: AGA
PLACEHOLDER
Switching from originator to biosimilar infliximab (IFX) is effective and safe. However, data on multiple switching are scarce. The Edinburgh IBD unit has undertaken three switch programmes: (1) Remicade to CT-P13 (2016), (2) CT-P13 to SB2 (2020), and (3) SB2 to CT-P13 (2021)…
A PHASE 2, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF PRA023 AS INDUCTION THERAPY IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE ULCERATIVE COLITIS: ARTEMIS-UC, COHORT 1
Switching from originator to biosimilar infliximab (IFX) is effective and safe. However, data on multiple switching are scarce. The Edinburgh IBD unit has undertaken three switch programmes: (1) Remicade to CT-P13 (2016), (2) CT-P13 to SB2 (2020), and (3) SB2 to CT-P13 (2021)…
